B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TUBA3C

MOLECULAR TARGET

tubulin alpha 3c

UniProt: P0DPH7NCBI Gene: 72789 compounds

TUBA3C (tubulin alpha 3c) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TUBA3C

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Colchicine4.86128
2Nocodazole Nocodazole is3.4330
3Podophyllotoxin2.9418
4Vincristine2.4811
5Demecolcine0.691
6Maytansine0.691
7Noscapine0.691
8vinblastine sulfate0.691
9Vorinostat0.691

About TUBA3C as a Drug Target

TUBA3C (tubulin alpha 3c) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented TUBA3C interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TUBA3C inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.